French Guiana Wellness Network
SEE OTHER BRANDS

Keeping up with health and wellness news from French Guiana

French Guiana Wellness Network: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on French Guiana Wellness Network.

Press releases published on August 13, 2025

Wound Care Management Devices Market Poised to Growth USD 30.0 Billion by 2035 with Thriving CAGR of  4.21%
Ophthalmology Device Market Forecasted to Reach USD 60.0 billion By 2035, at an Impressive 3.24% CAGR
Deep Brain Stimulation Device Market Anticipated to Reach USD 11.0 Billion, at a Notable 4.79% CAGR by 2035
Patient Lateral Transfer Device Market Set to Reach USD 3.2 Billion, with a Healthy 4.43% CAGR Till Forecasts 2035
Biofrontera Inc. Reports Second Quarter 2025 Financial Results and Provides a Business Update
Contraceptive Drugs and Devices Market Set to Achieve USD 75.0 Billion Valuation by 2035, Registering 4.31% CAGR
Lithotripsy Device Market Forecasted to Reach USD 2.5 Billion By 2035, at an Impressive 3.93% CAGR
BioSig Technologies Inc. Announces Proposed Public Offering
Veterinary Ultrasound Device Market Anticipated to Reach USD 2.5 Billion by 2035, Exhibiting a Remarkable 6.23% CAGR
Applied Therapeutics Reports Second Quarter 2025 Financial Results
Precipio Announces its Q2-2025 Financial Results
PharmaCorp Rx Inc. Announces New Credit Facilities With CIBC and Unveils Pharmacist Co-Ownership Financing Initiative
Implantable Drug Delivery Device Market Set to Grow at an Impressive CAGR of 7.38% Through 2035 | USD 12.5 Billion
LAVA Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Corza Medical ouvre un laboratoire d’innovation pour les textiles biomédicaux afin d’accélérer le développement de produits FEO
Corza Medical eröffnet Innovationslabor für biomedizinische Textilien zur Beschleunigung der OEM-Produktentwicklung
rYojbaba Co., Ltd. Announces Pricing of $5 Million Initial Public Offering of Japanese Common Shares and Listing on Nasdaq
2025 Winners of the 31st-Annual Eric Dostie Memorial College Scholarship Announced
SCYNEXIS Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Onco360 adds Modeyso™ (dordaviprone) to portfolio of Oncology and Rare Cancer therapies as a National Specialty Pharmacy Provider

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions